ProCE Banner Activity

Addressing ART Safety and Tolerability in Transgender Individuals

Podcast Episodes

Listen as 2 experts discuss approaches to ART safety and tolerability in transgender individuals, including clinically relevant drug interactions and additional considerations such as gender-affirming care.

Released: December 07, 2022

Expiration: December 06, 2023

No longer available for credit.

Share

Faculty

Jill Blumenthal

Jill Blumenthal, MD, MAS

Associate Professor of Medicine
Infectious Diseases and Global Public Health
University of California, San Diego
San Diego, California

Jennifer Cocohoba

Jennifer Cocohoba, PharmD

Professor
Department of Clinical Pharmacy
University of California, San Francisco
Pharmacist
Womens HIV Program
University of California San Francisco Medical Center
San Francisco, California

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from

Janssen Therapeutics, Division of Janssen Products, LP

ViiV Healthcare

Faculty Disclosure

Primary Author

Jill Blumenthal, MD, MAS

Associate Professor of Medicine
Infectious Diseases and Global Public Health
University of California, San Diego
San Diego, California

Jill Blumenthal, MD, MAS: researcher: Gilead Sciences.

Jennifer Cocohoba, PharmD

Professor
Department of Clinical Pharmacy
University of California, San Francisco
Pharmacist
Womens HIV Program
University of California San Francisco Medical Center
San Francisco, California

Jennifer Cocohoba, PharmD: researcher: Genentech, Janssen, ViiV Healthcare, Walgreens.